Skip to main content

Table 2 Antimicrobial profiling of the compound myricetin

From: Myricetin bioactive effects: moving from preclinical evidence to potential clinical applications

Strains Results References
Antiviral
 HIV Reverse Transcriptase 0.08 a [43]
 HIV Reverse Transcriptase, Moloney murine leukemia virus 0.08 b [53]
Antimicrobial
Gram positive
Actinomyces viscosus 20 b [54]
Burkholderia cepacia >512 b [55]
Corynebacterium diphtheriticum 18.2 e [56]
Enterococcus faecalis 17.0 e [56]
Enterococcus faecalis 2400 17.0 e [56]
Enterococcus faecium 16.8 e [56]
  Methicillin-resistant Staphylococcus aureus 256 b [55]
Staphylococcus aureus ATCC6538p > 300 c [57]
Staphylococcus aureus > 2000 b [58]
Staphylococcus epidermidis ATCC14490 64 b [55]
Staphylococcus epidermidis > 2000 b [58]
Staphylococcus epidermidis 17.4 e [56]
Staphylococcus saprophyticus 17.6 e [56]
Streptococcus mutans 20 b [54]
Streptococcus pneumoniae 49 128 b [55]
Streptococcus pneumoniae 17.4 e [56]
Streptococcus pyogenes 16.4 e [56]
  Vancomycin-Resistant Enterococci (VRE) 512 [55]
Gram negative
Burkholderia cepacia 64 b [55]
Enterobacter aerogenes 256 b [55]
Escherichia coli > 2000 b [58]
Escherichia coli WT 12.2 e [56]
Escherichia coli BU40 12.6 e [56]
Escherichia coli FPL5014 11.6 e [56]
Escherichia coli DnaB helicase 11.3 d [42]
Klebsiella pneumoniae ATCC13883 64 b [55]
Klebsiella pneumoniae 128 b [59]
Klebsiella pneumoniae > 2000 b [58]
Klebsiella pneumoniae 16.6 e [56]
Porphyromonas gingivalis 2500 b [54]
Prevotella intermedia 1250 b [54]
Proteus mirabilis 16.5 e [56]
Pseudomonas aeruginosa ATCC27853 256 b [55]
Pseudomonas aeruginosa > 2000 b [58]
Pseudomonas aeruginosa PAO286 15.6 e [56]
Salmonella paratyphi A 14.4 e [56]
Salmonella paratyphi B 14.4 e [56]
Salmonella typhi 14.4 e [56]
Shigella dysenteriae 15.5 e [56]
Shigella flexneri 13.4 e [56]
Shigella sonnei 14.6 e [56]
Anti-chlamydial
Chlamydia pneumoniae 29 c [60]
  1. Microbial strain is inserted when microbial type is repeated and information available
  2. aKi (μM)
  3. bminimum inhibitory concentration (MIC, μg/mL)
  4. cMIC (μM)
  5. dhalf maximal inhibitory concentration (IC50, μM)
  6. ezone of inhibition (ZOI, mm) for 100 μL of 0.5 mg/mL myricetin